Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-Equol in Alzheimer's Disease 2
NCT03101085Phase 2Completed
- Sponsor
- Russell Swerdlow
- Start
- May 2017
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of s-equol in Alzheimer's disease (AD), sponsored by Russell Swerdlow. Started May 2017; status: completed.
02
Drugs
s-equol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03101085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03101085.